Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy

Acta Oncologica

Volumn 42, Issue 2, 2003, Pages 160-168

  Knap, Marianne M ^a   Lundbeck, Finn ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; MUSCLE; PATIENT TREATMENT;

RADICAL CYSTECTOMY;

TUMORS;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CYSTECTOMY; DENMARK; DISEASE COURSE; DYING; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEUM; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTECTOMY; DENMARK; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0037688024     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310005039     Document Type: Article

References (35)

1. Fossa SD, Aass N, Ous S, Waehre H, Ilner K, Hannisdal E. Survival after curative treatment of muscle-invasive bladder cancer. Acta Oncol 1996; 35(Suppl 8): 59-65.
2. [Tumors of the urinary bladder. Report from a Committee of the Danish Urological Society from 1978]. Ugeskr Laeger 1982; 144: 1063-74.
3. [Urinary bladder tumors. Report of the Danish Bladder-cancer Committee 1993]. Ugeskr Laeger 1997; 159 (Suppl 1): 1-14.
4. Hermanek PSL. UICC TNM classification of malignant tumours, 4th ed. 2nd revised ed. Berlin: Springer-Verlag; 1992.
5. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.
6. Sobin LH, Greene FL. TNM classification clarification of number of regional lymph nodes for pN0. Cancer 2001; 92: 452.
7. Bassi P, Ferrante GD, Piazza N, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 1999; 161: 1494-7.
8. Nangia AK, Konety BR, Wachtel S, Dhir R, Becich MJ, Bahnson RR. Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomy. Urology 1997; 49: 968-72.
9. Heney NM, Proppe K, Prout GR, Jr, Griffin PP, Shipley WU. Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 1983; 130: 895-7.
10. Lerner SP, Skinner DG, Lieskovsky G, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993; 149: 758-64.
11. Pagano F, Bassi P, Galetti TP, et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45-50.
12. Vicente J, Laguna MP, Duarte D, Algaba F, Chechile G. Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours. Br J Urol 1991; 68: 380-2.
13. Haukaas S, Daehlin L, Maartmann-Moe H, Ulvik NM. The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: a single-institutional experience. BJU Int 1999; 83: 957-63.
14. Holmang S, Johansson SL. Stage Ta-Tl bladder cancer: the relationship between findings at first follow-up cystoscopy and subsequent recurrence and progression. J Urol 2002; 167: 1634-7.
15. Yiou R, Patard JJ, Benhard H, Abbou CC, Chopin DK. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. Br J Urol Int 2002; 89: 374-8.
16. Primdahl H, Von Der MH, Christensen M, Wolf H, ORntoft TF. Allelic deletions of cell growth regulators during progression of bladder cancer. Cancer Res 2000; 60: 6623-9.
17. Primdahl H, Von Der MH, Sorensen FB, Wolf H, ORntoft TF. Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer. J Cancer Res Clin Oncol 2002; 128: 295-301.
18. Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 2000; 88: 2326-32.
19. Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24: 980-7.
20. Sengelov L, Kamby C, von der Maase H. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol 1996; 155: 111-4.
21. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1 054 patients. J Clin Oncol 2001; 19: 666-75.
22. Greven KM, Spera JA, Solin LJ, Morgan T, Hanks GE. Local recurrence after cystectomy alone for bladder carcinoma. Cancer 1992; 69: 2767-70.
23. Sengelov L, von der Maase H. Radiotherapy in bladder cancer. Radiother Oncol 1999; 52: 1-14.
24. Wesmey OL, Pisters LL, Pettaway CA, Tu SM, Pollack A, Dinney CP. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1998; 159: 792-5.
25. Sengelov L, von der Maase H, Kamby C, et al. Assessment of patients with metastatic transitional cell carcinoma of the urinary tract. J Urol 1999; 162: 343-6.
26. Roehrborn CG, Sagalowsky AI, Peters PC. Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol 1991; 146: 36-9.
27. Frazier HA, Robertson JE, Dodge RK, Paulson DF. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993; 71: 3993-4001.
28. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165: 1111-6.
29. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994; 73: 1926-31.
30. Vieweg J, Gschwend JE, Herr HW, Fair WR. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999; 161: 72-6.
31. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9.
32. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Br J Urol Int 2000; 85: 817-23.
33. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-8.
34. Sternberg CN. Current perspectives in muscle invasive bladder cancer. Eur J Cancer 2002; 38: 460-7.
35. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann Oncol 2000; 11: 851-6.